Ignite Creation Date:
2025-12-24 @ 11:58 AM
Ignite Modification Date:
2025-12-29 @ 3:10 PM
Study NCT ID:
NCT06033261
Status:
COMPLETED
Last Update Posted:
2025-05-08
First Post:
2023-09-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of mRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital Herpes
Sponsor:
ModernaTX, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-09-06
Start Date Type:
ACTUAL
Primary Completion Date:
2025-04-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-04-25
Completion Date Type:
ACTUAL
First Submit Date:
2023-09-05
First Submit QC Date:
None
Study First Post Date:
2023-09-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-06
Last Update Post Date:
2025-05-08
Last Update Post Date Type:
ACTUAL